Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

US Patent 10562968 · Granted Feb 18, 2020

Estimated economic value: $144,579,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR and C-met fibronectin type III domain binding molecules2025
GPRC5D chimeric antigen receptors and cells expressing the same2024
GPRC5D chimeric antigen receptors and cells expressing the same2024
GPRC5D chimeric antigen receptors and cells expressing the same2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Variable heavy chain only libraries, methods of preparation thereof, and uses th2024
Vaccines based on mutant CALR and JAK2 and their uses2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024